ACELRX PHARMACEUT. DL-01 (R5XA) — Cash Flow Quality Index
ACELRX PHARMACEUT. DL-01 (R5XA) has a Cash Flow Quality Index of -0.67x as of December 2022. Operating cash flow of €-28.33 Million is below net income of €42.33 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of ACELRX PHARMACEUT. DL-01 for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ACELRX PHARMACEUT. DL-01 Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for ACELRX PHARMACEUT. DL-01 across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check R5XA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ACELRX PHARMACEUT. DL-01 (2022–2022)
Year-by-year earnings quality comparison for ACELRX PHARMACEUT. DL-01. For live market cap and the full company financial profile, see ACELRX PHARMACEUT. DL-01 (R5XA) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.67x | €-28.33 Million | €42.33 Million | — |